Role of Glutathione Peroxidase in Health and Disease

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: 31 December 2024 | Viewed by 65

Special Issue Editor


E-Mail
Guest Editor
Department of Cancer Genetics and Epigenetics, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USA
Interests: antioxidant enzymes; GPX; cancer; mouse models; cell lines

Special Issue Information

Dear Colleagues,

Selenium (Se)-dependent glutathione peroxidases (GPX) and now, Se-independent GPXs, have been linked to disease (Kashan) and numerous pathologies, cancer foremost (10% of publications). The Guest Editor, in reviewing GPX2 work, found technical flaws, errors in interpretation, and, often, results that defied understanding in much of the work. This Special Issue is soliciting work on GPXs and health (stock animals, poultry, and humans) that truly advances the field and meets higher standards of workmanship than most papers currently accepted for publication. Reviews pointing out the items mentioned above will not be considered. Ferroptosis papers must feature GPX4 as the focus or be rejected. To promote reproducibility, the editor encourages the use of Se supplementation in cell culture. In cell line work using mRNA silencing or overexpression, the impact on protein levels must be shown in a single Western blot with all the parental lines included or with reference high- and low-expressing lines; likewise, for RT-PCR. In work involving GPX2, the GPX1 expression must be included as part of the data. In work using 2’,7’-dichlorodihydrofluorescein diacetate, testing resistance to oxidants or impact on cell properties, a second comparable antioxidant enzyme should be silenced or overexpressed to support the results (GPX1, where GPX2 is studied; PRDX1, or 2, where GPX1 is studied, etc.). Kaplan–Meier (K–M) curves should have cut-offs that make sense relative to significant expression levels, not always median levels. Cell lines used to validate K–M analysis should have comparable TPM (tumors extrapolated to 100% purity). IHC-based K–M analyses should show intensity and proportion separately.

Dr. R Steve Esworthy
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • GPX1
  • GPX2
  • GPX3
  • GPX4
  • GPX5
  • GPX6
  • GPX7
  • GPX8
  • selenium
  • cancer
  • pathology

Published Papers

This special issue is now open for submission.
Back to TopTop